Company · CIK 1290877

# Clinuvel Pharmaceuticals Ltd

| CIK | [1290877](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001290877) (SEC EDGAR) |
| --- | --- |
| Industry (SIC) | 8880 — American Depositary Receipts |
| Incorporated in | C3 |
| Listed | CUVL (Nasdaq), CLVLF (OTC) |
| First annual or quarterly report | none on EDGAR |

## Offerings

 0 registrations

No offering chain starts here after 2002-11-04: the company's filings belong to registrations filed earlier, or to drafts and notices only.

## Filings

 2

| Filed | Filing | Registration | Accession |
| --- | --- | --- | --- |
| 2025-12-18 | [DRS](https://www.sec.gov/Archives/edgar/data/1290877/000149315225028243/0001493152-25-028243-index.htm) Draft made public | 377-08830 | 0001493152-25-028243 |
| 2021-08-16 | [EFFECT](https://www.sec.gov/Archives/edgar/data/1290877/999999999521003223/9999999995-21-003223-index.htm) Declared effective | 333-258570 | 9999999995-21-003223 |

[All filings of this company](https://equitycapital.markets/filings?cik=1290877) · [CSV](https://equitycapital.markets/filings.csv?cik=1290877)

---
Source page: https://equitycapital.markets/company/1290877 · Data: U.S. SEC EDGAR · CC BY 4.0